Gsk Share Discussion Threads

[longwell] 02/11/2022 07:34

Guidance for year revised up and outlook for 2023 will continue with strength.Buy the trend.

[netcurtains] 02/11/2022 07:24

Two bits of interesting news today. Results and Vaccine update.

[lippy4] 01/11/2022 15:20

finger crossed!!

[tradermichael] 01/11/2022 13:34

The positive impact of foreign exchange on Q3 2022 sales will be around +9%

[tradermichael] 01/11/2022 13:29

Yes, its all about tomorrow .....

2022 Third quarter
02 November 2022
We will announce our third quarter 2022 results on Wednesday 2 November at 07:00 GMT, 03:00 EDT.

Following the announcement there will be a webcast hosted by Emma Walmsley, CEO, and other members of the GSK Leadership Team at 12:00 GMT, 08:00 EDT.

[supermarky] 01/11/2022 13:13

Lets see the numbers and how they are interpreted. Nice to see some positive moves up over the last few weeks though

[purchaseatthetop] 31/10/2022 19:05

Looking better and better. Happy days snd recovery underway.

[netcurtains] 28/10/2022 13:08

Looks like its beginning to struggle to hold 1400. Be great if it closes above that number, it took so long to get here.

[tuftymatt] 28/10/2022 11:35

£18 seems a leap from here but we were there just 4 months ago so it's really possible.

Waiting to add on a bit of a dip but we are just not seeing it right now 👍🏻

[netcurtains] 28/10/2022 10:44

"
Despite this, Broker Shore Capital says there is a “value disconnect” in GSK’s share price. In a note to investors, analyst Dr Susie Jana said with GSK shares trading at 9.9 times 2023 earnings, versus peers at an average of 14.8 times, GSK’s fair value is at £18 per share, suggesting around 32% upside.
"

[pol123] 28/10/2022 08:53

I'm waiting for £12...haha

Good news on the HIV treatment this AM

[netcurtains] 28/10/2022 08:38

Its done.
Phew!
Be interesting to see where it settles.
I guess it depends on results.

[stewart64] 28/10/2022 08:37

Broken it now. Too cheap for what is now a Pharma. What are you going to load up on to balance your portfolio..AZN with a P/E of 75 over the last 5 years ( 10 billion profit over those years in total with a Cap of 150 billion) or bombed out GSK.

[tradermichael] 27/10/2022 11:24

Yes, there is a perceived 'barrier' to a round number like 1400p

[netcurtains] 27/10/2022 11:21

pyschological

[anhar] 27/10/2022 10:44

And what is the significance of 1,400p? Nothing but roundnumberism, attributing meaning to a figure that cannot have any. I know round numbers sound nice but the market or the share itself doesn't care about that at all. So 1,400 is no more important than 1,399 or 1,401 etc.

[netcurtains] 27/10/2022 09:41

If its going to break 1400, its quite possible it will do it today.

[geckotheglorious] 26/10/2022 13:38

Worth cursory glance for all but the LT hodlers here.
More a historical walk down memory lane truth be told...

”Is GSK a good choice for dividend investors”

[netcurtains] 26/10/2022 12:59

Its an automated process so it does not take into account the info that you know.
Perhaps write to google?

[anhar] 26/10/2022 12:52

...currently, the dividend yield is 6.79% (Googles figures)...

I don't know how they calculated that but it is much too high, see my post no. 31064 where I show that the forecast yield on the 2023 expected divi of 56.5p is 4.1% at 1,371p and little different at the current 1,384p.

A historical yield for GSK, if that's how they worked it out, will be unrealistically high because the divi is being cut.

[netcurtains] 25/10/2022 16:00

Its struggling to break 1400.
Do you think the results will be a blinder?

currently, the dividend yield is 6.79% (Googles figures).
PE ratio 10.68 (Googles figures).

[1knocker] 25/10/2022 11:38

Having held GSK for a decade, I got out completely earlier this year at an average of 17.50. Bought a few (10%)back last month, and just in the blue on that purchase. Any big restructuring is a risk. The lower dividend makes sense, but costs of drug development are eye watering, and there must be some limit to what consumers will pay. SPs across the sector seem high to me, A few months ago I sold 20% (I now wish I had been more decisive and sold more)of my Astrazeneca holding at !!4 and bought back a week or so ago at just under 97. But even at 80 they would still be pretty expensive. I do fear a sector price fall, which could see GSK down a couple of quid. Very difficult to know what to do, though its not a sector one can ignore in a balanced portfolio. That said, I am happy to be overweight energy and basic materials rather than big pharma.I guess we all just have to take every opportunity to trade down the capital cost of our Pharma and hope for the best. Certainly that has proved the right tactic this year with GSK and AstrZ.

[geckotheglorious] 25/10/2022 10:49

November is when Pfizer can start selling I gather...so not long to find out their intentions.

[netcurtains] 25/10/2022 08:07

Haleon seems to be doing well recently. Hopefully it will continue